Watchlist Price Alert

BioMarin Pharmaceutical I... (BMRN)

NASDAQ: BMRN · Real-Time Price · USD

56.74

1.47 (2.66%)

At close: Jun 06, 2025, 1:56 PM

BioMarin Pharmaceutical Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	942.84M	755.13M	724.53M	587.28M	649.16M	437.45M	493.98M	598.03M	408.33M
Short-Term Investments	194.86M	318.68M	567.01M	426.6M	416.23M	316.36M	590.33M	797.94M	381.35M
Long-Term Investments	521.24M	611.13M	333.83M	507.79M	285.47M	411.98M	235.86M	385.79M	572.71M
Other Long-Term Assets	251.39M	125.46M	176.24M	151.76M	142.24M	122.01M	36.57M	29.85M	32.81M
Receivables	660.53M	633.7M	461.32M	373.4M	448.35M	377.4M	342.63M	261.37M	215.28M
Inventory	1.23B	1.11B	894.08M	776.67M	698.55M	680.27M	530.87M	475.77M	355.13M
Other Current Assets	201.53M	141.39M	104.52M	110.44M	129.93M	130.66M	98.4M	74.04M	61.71M
Total Current Assets	3.23B	2.96B	2.75B	2.27B	2.34B	1.94B	2.06B	2.21B	1.42B
Property-Plant & Equipment	1.04B	1.11B	1.07B	1.04B	1.03B	1.01B	948.68M	896.7M	798.77M
Goodwill & Intangibles	451.48M	490.9M	534.77M	584.85M	613.47M	653.62M	688.85M	714.55M	750.82M
Total Long-Term Assets	3.76B	3.89B	3.62B	3.73B	3.51B	2.75B	2.37B	2.43B	2.6B
Total Assets	6.99B	6.84B	6.38B	6B	5.85B	4.69B	4.43B	4.63B	4.02B
Account Payables	235.4M	315.51M	231.24M	193M	191.43M	240.98M	207.62M	166.62M	191.35M
Deferred Revenue	1.37M	4.62M	711K	6.96M	152K	13.04M	n/a	n/a	n/a
Short-Term Debt	n/a	493.88M	n/a	n/a	n/a	361.88M	n/a	360.95M	22.48M
Other Current Liabilities	223.14M	150.52M	122.77M	123.74M	114.53M	113.44M	165.68M	142.64M	116.44M
Total Current Liabilities	606.99M	1.18B	588.88M	539.82M	492.55M	932.5M	523.24M	816.52M	439.31M
Long-Term Debt	595.14M	593.1M	1.08B	1.08B	1.08B	486.24M	830.42M	813.52M	660.76M
Other Long-Term Liabilities	128.82M	119.94M	100.02M	79.84M	174.32M	148.92M	105.53M	194.42M	157.34M
Total Long-Term Liabilities	723.96M	713.03M	1.18B	1.19B	1.25B	635.15M	935.95M	1.01B	818.11M
Total Liabilities	1.33B	1.89B	1.77B	1.73B	1.74B	1.57B	1.46B	1.82B	1.26B
Total Debt	602.71M	1.1B	1.08B	1.08B	1.08B	848.12M	830.42M	1.17B	683.24M
Common Stock	191K	189K	186K	184K	182K	180K	178K	176K	173K
Retained Earnings	-194.69M	-621.55M	-789.2M	-925.69M	-861.61M	-1.72B	-1.69B	-1.64B	-1.52B
Comprehensive Income	61.65M	-38.65M	-3.87M	14.43M	-16.14M	20.16M	5.27M	-22.96M	12.82M
Shareholders Equity	5.66B	4.95B	4.6B	4.27B	4.11B	3.12B	2.97B	2.81B	2.77B
Total Investments	716.1M	929.82M	900.84M	934.39M	701.7M	728.34M	826.19M	1.18B	958.12M